Patents Represented by Attorney, Agent or Law Firm Alan L. Scrivner, Esq.
  • N-substituted dithiocarbamates for the treatment of biological disorders
    Patent number: 6747061
    Abstract: N-substituted dithiocarbamate esters, pharmaceutical compositions containing them, and methods of treating hyperproliferative disorders such as cancer by administering the N-substituted dithiocarbamate esters.
    Type: Grant
    Filed: March 21, 2001
    Date of Patent: June 8, 2004
    Assignee: AtheroGenics, Inc.
    Inventors: Russell M. Medford, Uday Saxena, Lee K. Hoong, Patricia K. Somers
  • Compounds and methods for treating transplant rejection
    Patent number: 6670398
    Abstract: The use of compounds of the formula and pharmaceutically acceptable salts thereof, alone or in combination for the treatment of transplant rejection, wherein the substituents are further defined in the application.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: December 30, 2003
    Assignee: AtheroGenics, Inc.
    Inventors: David B. Edwards, Patricia K. Somers, Mitchell Glass